Description: Benzyl benzoate -Human Insulin Analogue Glargine Recombinant DNA origin 450 IU or 1 point 5 ml PFS Disposable Pen with 5 needles per pen:Patient Care; Insulin Glulisine Injection Cartridge 100 IU or ml of 03 ml:Patient Care; Inj Insulin Aspart 100 U or ml of 3 Ml Pen:Patient Care; Insulin Aspart 50 percent plus Protamin Crystallised Aspart 50 percent 100 Iu or Ml of 3Ml Pen:Patient Care; Insulin Humalog Lispro Inj Recombinan Dna Origin 100 IU or ml of 3 ml cartridge:Patient Care; Soluble Insulin Injection 40 IU or ml of Human Actrapid Vial of 10 ml:Patient Care;
Details: Human Insulin Analogue Glargine Recombinant DNA origin 450 IU or 1 point 5 ml PFS Disposable Pen with 5 needles per pen , Insulin Glulisine Injection Cartridge 100 IU or ml of 03 ml , Inj Insulin Aspart 100 U or ml of 3 Ml Pen , Insulin Item Category/ Aspart 50 percent plus Protamin Crystallised Aspart 50 percent 100 Iu or Ml of 3Ml Pen , Insulin Humalog Lispro Inj Recombinan Dna Origin 100 IU or ml of 3 ml cartridge , Soluble Insulin Injection 40 IU or ml of Human Actrapid Vial of 10 ml Human Insulin Analogue Glargine (Recombinant DNA origin) 450 IU/1.5 ml PFS Disposable Pen with 5 needles per pen, Insulin Glulisine Injection Cartridge 100 IU/ ml, 03 ml, Inj
Sector: Defense